Skip to content
Back to CMS Watch
CMS WatchNovember 11, 2026·6 min read

HH grouper v08.0.27 for 2027: diabetes joins the low comorbidity list, lupus and lung cancer drop off

CMS posted the January 2027 home health grouper (v08.0.27) and the CY2027 HH PPS rate change request, CR 14668. As secondary diagnoses, diabetes, atherosclerosis and PVD, other kidney disorders, and COVID-19 now earn the low comorbidity adjustment, while lupus and lung cancer no longer do.

Home healthPDGMHH grouperComorbidity adjustmentCY2027
HCC Buddy

By the HCC Buddy Coding Team

Published November 11, 2026

Home health coding desk with a small house model, a clipboard, a tray of tagged cards, and a January calendar for the 2027 grouper update
CMS posted the January 2027 home health grouper, v08.0.27, on November 5, 2026. It applies to claims starting January 1, 2027. — Image: HCC Buddy

Key Takeaways

  • →CMS posted the January 2027 Home Health PPS Grouper software, version 08.0.27, on November 5, 2026 for home health claims starting January 1, 2027. CMS says the release has no logic or interface changes; it updates the clinical group thresholds, functional impairment points, low comorbidity list, and high comorbidity interaction pairs.
  • →In home health grouper v08.0.27, four comorbidity subgroups are added to the low comorbidity adjustment list: Type 1, Type 2, and Other Specified Diabetes (Endocrine_3); Atherosclerosis, including Peripheral Vascular Disease, Aortic Aneurysms and Hypotension (Circulatory_7); Other disorders of the kidney and ureter (Renal_3); and 2019 Novel Coronavirus (Respiratory_10).
  • →Home health grouper v08.0.27 removes Lupus (Musculoskeletal_1) and Malignant Neoplasm of Trachea, Bronchus, Lung, and Mediastinum (Neoplasm_6) from the low comorbidity adjustment list, taking the list from 20 subgroups in the October 2026 grouper (v07.2.26) to 22.
  • →The v08.0.27 grouper adds 51 high comorbidity interaction pairs and deletes 46, for 103 pairs in total, matching the 22 low and 103 high subgroups CMS finalized in the CY2027 Home Health PPS final rule (CMS-1844-F).
  • →CMS Change Request 14668 (Transmittal 14031), posted November 10, 2026, sets the CY2027 national standardized 30-day period payment at $2,092.69 for agencies that submit quality data, with a 2.1% payment update and a 0.29 fixed-dollar loss ratio, for claims with Through dates on or after January 1, 2027.

On November 5, 2026, CMS posted the January 2027 Home Health PPS Grouper software, version 08.0.27, for home health claims starting January 1, 2027. Five days later, on November 10, CMS posted Change Request 14668, the CY2027 Home Health PPS rate update that tells Medicare contractors how to pay those claims. Together they carry the lists and rates from the CY2027 home health final rule into the grouper and the Pricer.

For home health coders, the change to watch is which secondary diagnoses earn a comorbidity adjustment. Diabetes is now on the low comorbidity list, and lupus and lung cancer are off it.

What's in home health grouper v08.0.27

CMS says v08.0.27 has no logic or interface changes. It updates four sets of grouper tables effective January 1, 2027:

  • Clinical group thresholds for the low, medium, and high functional impairment levels
  • Functional impairment response points for certain OASIS items
  • The comorbidity group table, which marks the subgroups that earn a low comorbidity adjustment
  • The comorbidity interaction table, which lists the subgroup pairs that earn a high comorbidity adjustment

CMS also notes that the grouper now runs on Java 17. Agencies and vendors who run it in a mainframe environment get one COBOL Java bridge module that uses the 64-bit Java 17 environment.

Diabetes joins the low comorbidity list

Under the PDGM, a 30-day period gets the low comorbidity adjustment when a reported secondary diagnosis falls in a subgroup on the home health comorbidity list. It gets the high adjustment when two reported secondary diagnoses form one of the listed interaction pairs. The final rule describes both.

In the grouper's comorbidity tables, the October 2026 release (v07.2.26) flags 20 subgroups for the low adjustment and v08.0.27 flags 22. Four are added and two are removed:

Comorbidity subgroupExample ICD-10-CM code in the subgroupv08.0.27 change
Endocrine_3: Type 1, Type 2, and Other Specified DiabetesE11.9Added to low list
Circulatory_7: Atherosclerosis, includes Peripheral Vascular Disease, Aortic Aneurysms and HypotensionI73.9Added to low list
Renal_3: Other disorders of the kidney and ureter, excluding chronic kidney disease and ESRDSee the grouper tableAdded to low list
Respiratory_10: 2019 Novel CoronavirusU07.1Added to low list
Musculoskeletal_1: LupusM32.9Removed from low list
Neoplasm_6: Malignant Neoplasm of Trachea, Bronchus, Lung, and MediastinumC34.90Removed from low list

The example codes map to the same subgroups in both grouper versions. What changed is whether that subgroup earns the low adjustment. Diabetes with neuropathy (Neurological_10, which includes E11.40) was already on the low list and stays there.

Tray of tagged cards with two raised and two set aside, beside a small house model, for the 2027 home health comorbidity changes
Grouper v08.0.27 adds four subgroups to the low comorbidity list and removes two.

High comorbidity pairs: 51 added, 46 deleted

The interaction table changes more. CMS's summary of data changes for v08.0.27 lists 51 added pairs and 46 deleted pairs, for 103 pairs in the new table. That matches the 22 low and 103 high subgroups CMS finalized in the CY2027 rule.

A few pairs show how much the list moved:

  • Added: diabetes (Endocrine_3) with stage 2 through 4 and unstageable pressure ulcers (Skin_4), and diabetes with cutaneous abscess, cellulitis, and lymphangitis (Skin_1).
  • Deleted: sequelae of cerebrovascular disease (Cerebral_4) with diabetes (Endocrine_3).

So a stroke-sequelae patient with diabetes no longer earns the high adjustment from that pair, while diabetes on its own now earns the low adjustment. Check every pair your agency sees often against the new table, not your CY2026 tip sheet. The summary of data changes in the download is labeled preliminary, so recheck it against the final CMS-1844-F lists.

Functional thresholds and OASIS points

Eleven of the twelve clinical groups get new functional impairment thresholds. MMTA - Surgical Aftercare is the one that doesn't change. Here's where the high functional impairment level now starts:

Clinical groupPrevious high levelHigh level for 2027
MMTA - Other46+43+
Neuro Rehabilitation53+51+
Wound53+51+
Complex Nursing Interventions55+56+
Musculoskeletal Rehabilitation46+45+
Behavioral Health47+45+
MMTA - Cardiac and Circulatory44+43+
MMTA - Endocrine42+43+
MMTA - Gastrointestinal tract and Genitourinary system49+47+
MMTA - Infectious Disease, Neoplasms, and Blood-Forming Diseases47+45+
MMTA - Respiratory47+45+

Point values also change for responses to five OASIS items. M1850 (transferring) gains points: response 1 goes from 1 to 3, and responses 2 through 5 go from 4 to 5. M1033 (risk of hospitalization), M1820 (dress lower body), M1830 (bathing), and M1860 (ambulation) lose a point or two on certain responses.

CR 14668: CY2027 home health rates on the claim

CR 14668 is Transmittal 14031. It's dated October 29, 2026 and was re-communicated for public posting on November 10. It's effective January 1, 2027, with a January 4, 2027 implementation date. Contractors apply the CY2027 rates to periods with claim Through dates on or after January 1, 2027.

CY2027 item in CR 14668Amount
Payment update (3.1% market basket minus 1.0 point productivity)2.1%
Update for agencies that don't submit quality data0.1%
National standardized 30-day period payment (with the 0.9700 temporary adjustment factor)$2,092.69
Same, for agencies that don't submit quality data$2,051.70
Skilled nursing per-visit rate$180.66
Physical therapy per-visit rate$197.46
Fixed-dollar loss ratio for outliers0.29
Disposable negative pressure wound therapy device$289.15

The LUPA add-on factors stay at 1.7200 for skilled nursing, 1.6225 for physical therapy, 1.6696 for speech-language pathology, and 1.7238 for occupational therapy. Billers should note requirement 14668.4. It tells contractors to instruct providers to report the CBSA code, or a special 500xx wage index transition code, for the patient's state and county of residence in value code 61. Table 6 of the CR lists the affected counties with their CY2027 500xx transition codes.

CMS also posted CR 14671 on November 10 with the CY2027 home infusion therapy services rates, a 2.5% update for HCPCS G0068 through G0070 and G0088 through G0090. Those are HCPCS codes, so check them in the CMS files. HCC Buddy's Code Book and encoder cover ICD-10-CM diagnosis codes only.

What home health coders should do before January 1

Start with the secondary diagnoses. A documented type 2 diabetes diagnosis that isn't coded on the claim can't earn the new low adjustment, and lupus or lung cancer alone no longer earns one. Use the Code Book to confirm the full ICD-10-CM code, then check its subgroup in the grouper's diagnosis table.

Next, ask your billing vendor when it will load v08.0.27 and the CY2027 Pricer, and whether it tested the Java 17 change. And for the rest of the CY2027 home health picture, see the January 2027 home health consolidated billing HCPCS update (CR 14639).

What coders should do now

  1. 1Update your home health comorbidity tip sheet for January 1, 2027: add diabetes (Endocrine_3), atherosclerosis and PVD (Circulatory_7), other kidney and ureter disorders (Renal_3), and COVID-19 (Respiratory_10) to the low list, and take off lupus (Musculoskeletal_1) and lung cancer (Neoplasm_6).
  2. 2Check that documented diabetes is coded as a secondary diagnosis on home health claims with From dates on or after January 1, 2027, since Endocrine_3 now earns the low comorbidity adjustment on its own.
  3. 3Compare your agency's most common diagnosis pairs with the v08.0.27 interaction table: 51 pairs were added and 46 deleted, including the stroke sequelae plus diabetes pair that no longer earns the high adjustment.
  4. 4Ask your billing vendor when it will load grouper v08.0.27 and the CY2027 HH PPS Pricer, and confirm value code 61 carries the right CBSA or 500xx transition code for each patient's county.

Frequently Asked Questions

Does type 2 diabetes count for the home health comorbidity adjustment in 2027?

Yes. In the January 2027 home health grouper, v08.0.27, the Type 1, Type 2, and Other Specified Diabetes subgroup (Endocrine_3) is on the low comorbidity list for claims starting January 1, 2027. In the CMS grouper tables, E11.9 maps to Endocrine_3. The diagnosis has to be reported as a secondary diagnosis on the claim.

Which subgroups came off the home health low comorbidity list for 2027?

Two: Lupus (Musculoskeletal_1) and Malignant Neoplasm of Trachea, Bronchus, Lung, and Mediastinum (Neoplasm_6). CMS's summary of data changes for grouper v08.0.27 lists both as removed from the low comorbidity adjustment list.

When does home health grouper v08.0.27 take effect?

CMS posted v08.0.27 on November 5, 2026 for home health claims starting January 1, 2027. CMS's grouper version file runs v08.0.27 from January 1, 2027, after v07.2.26 ends December 31, 2026.

What does value code 61 mean on a 2027 home health claim?

Under CR 14668, Medicare contractors instruct home health agencies to report the CBSA code, or a special 500xx wage index transition code, for the patient's state and county of residence in value code 61. Table 6 of CR 14668 lists the affected counties with their CY2027 500xx transition codes.

Related topics:Home healthPDGMHH grouperComorbidity adjustmentCY2027
HCC Buddy

HCC Buddy Coding Team

Editorial

Every HCC Buddy news article is checked against the current CMS-HCC model and the active FY ICD-10-CM tabular release before it publishes.

Get CMS Updates in Your Inbox

RADV news, model changes, and coding guidance — within days of CMS publishing, not quarters.